Correspondence from the Medicines & Healthcare products Regulatory Agency in relation to the authorisation of clinical trial research, dated 12 March 2024
Published: | Thursday 21 March 2024 @ 09:00 |
---|---|
Publication type: | Correspondence |
Committee: | Science, Innovation and Technology Committee |
Files
-
05 MHRA letter on authorising clinical trial research.pdf
File size: 67614